PriceTargets.com logo

ANGLE - AGL Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 2.35 As of 10/28/2025 01:28 PM ET
▼ -0.3 (-11.32%)

This chart shows the closing price for AGL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ANGLE Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AGL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AGL

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for ANGLE in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 2.35.

This chart shows the closing price for AGL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in ANGLE. This rating has held steady since January 2026, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/5/2026

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/29/2025Berenberg BankReiterated RatingBuyGBX 40
9/26/2024Berenberg BankReiterated RatingBuyGBX 70
4/24/2024Berenberg BankReiterated RatingBuyGBX 70
5/25/2023Berenberg BankReiterated RatingBuyGBX 120
4/21/2023Berenberg BankReiterated RatingBuyGBX 120
1/5/2023Berenberg BankLower TargetBuyGBX 241 ➝ GBX 120
8/5/2022Berenberg BankReiterated RatingBuyGBX 231
5/23/2022Berenberg BankReiterated RatingBuyGBX 195
5/13/2022Berenberg BankReiterated RatingBuyGBX 195
4/28/2022Berenberg BankReiterated RatingBuyGBX 195
1/20/2022Berenberg BankInitiated CoverageBuyGBX 195
(Data available from 3/5/2021 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/4/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/3/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/5/2026

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
ANGLE logo
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Read More

Today's Range

Now: GBX 2.35
Low: 2.33
High: 2.90

50 Day Range

MA: GBX 2.35
Low: 2.35
High: 2.35

52 Week Range

Now: GBX 2.35
Low: 1.50
High: 17.45

Volume

1,682,496 shs

Average Volume

1,623,727 shs

Market Capitalization

£7.58 million

P/E Ratio

N/A

Dividend Yield

1.12%

Beta

0.22

Frequently Asked Questions

What sell-side analysts currently cover shares of ANGLE?

The following Wall Street analysts have issued reports on ANGLE in the last year:
View the latest analyst ratings for AGL.

What is the current price target for ANGLE?

0 Wall Street analysts have set twelve-month price targets for ANGLE in the last year. has the lowest price target set, forecasting a price of £100,000 for ANGLE in the next year.
View the latest price targets for AGL.

What is the current consensus analyst rating for ANGLE?

ANGLE currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for AGL.

What other companies compete with ANGLE?

Other companies that are similar to ANGLE include Future Metals, Burning Rock Biotech, Connemara Mining, Amedeo Resources and Shaftesbury Capital. Learn More about companies similar to ANGLE.

How do I contact ANGLE's investor relations team?

ANGLE's physical mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company's listed phone number is +44-1483-685830. The official website for ANGLE is www.angleplc.com. Learn More about contacing ANGLE investor relations.